InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Haddadin Yezan Munther, Director. Director active across 1 companies, notably Outlook Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €25k. The latest transaction was filed on 2 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€12,28010,000 shares@ €1.2280.045% mcap100.0% of flow
Common Stock
SEC:0001209191-21-067650·
Ideal exit: 29 Aug 2022 (T+270)
€12,28010,000 shares@ €1.2280.045% mcap50.0% of flow
Common Stock
SEC:0001209191-21-067650:0·
Ideal exit: 29 Aug 2022 (T+270)
2 of 2 declarations
About Haddadin Yezan Munther
Yezan Munther Haddadin is a Board Member at Outlook Therapeutics, Inc. As a board member, he plays a key role in the governance of the company. His experience and business acumen are essential in guiding strategic decisions and ensuring compliance with regulatory standards. He also contributes to overseeing the company's performance.
